- High-speed, low-dose scanner enables consistent, high-quality imaging in cardiac and trauma settings
Includes myExam Companion intelligent user interface and new myNeedle Companion for planning and guidance of CT-guided interventional procedures
Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the SOMATOM X.ceed, a premium single-source computed tomography scanner that combines high-speed scanning capabilities and a level of resolution previously unseen in other single-source CT systems with a new hardware/software combination to simplify CT-guided interventions. Possessing the largest bore for a diagnostic CT scanner at 82 cm, the scanner is designed for all diagnostic procedures, particularly cardiac and trauma imaging. With these and other features, the SOMATOM X.ceed expands precision medicine and transforms care delivery.
Several key design features of the SOMATOM X.ceed differentiate it from other single- source CT scanners. It has the fastest rotation speed1 on a single-source CT at 0.25s to ensure a high native temporal resolution and reduce motion artifacts when scanning moving structures such as the heart. It possesses the fastest scan speed1 at 262mm/s for consistent image quality across the entire field of view. Additionally, the scanner has the smallest focal point1, at 0.4x0.5, for increased spatial resolution to better aid in the detection of deep-seated small and medium lesions. And with 1300 mA power reserves, it also has the highest power,1 enabling a high level of image quality for larger patients while expanding the utilization of low dose and low contrast media techniques, such as low kV imaging.
Through ongoing development and refinement of data interfaces, Siemens Healthineers aims to increase the number of disease parameters captured throughout the clinical pathway, thereby expanding the relevant data points with the goal of advancing cancer care. The company looks forward to partnering with even more healthcare institutions on optimizing the AI-Pathway Companion solution to their routine clinical practice and preferred lung cancer workflow.
A key feature of the SOMATOM X.ceed is myNeedle Companion, a new approach to CT- guided interventions that combines hardware innovations and intuitive software to coordinate the planning and guidance of percutaneous needle procedures. One version of myNeedle Companion includes myNeedle 3D, a fully integrated software package that supports complex interventional procedures and includes as an option the world’s first scanner-integrated laser guidance system. Established myExam Companion user guidance software employs artificial intelligence to help simplify and standardize scanner operation for each user. myExam Companion also provides a new decision tool for trauma imaging, and the new myExam Satellite feature allows immediate assessment of CT perfusion results, which can be valuable in emergency radiology.
“With the SOMATOM X.ceed, Siemens Healthineers expands its portfolio of high-end, single-source CT scanners that leverages the myExam Companion intelligent user interface to standardize and streamline workflows as well as provide optimal image quality at the lowest possible dose,” said Douglas Ryan, Vice President of the Computed Tomography business at Siemens Healthineers North America. “The addition of myNeedle Companion can help healthcare professionals perform simple and complex interventional procedures with greater confidence. And the high image quality resulting from the scanner’s fast rotation and scan speeds, coupled with its high resolution, can help lead to more informed decisions.”
1 Based on competitive literature available at time of publication. Data on file.
Siemens Healthineers Media Contact
Phone: +484-868-8346; Email: firstname.lastname@example.org
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare.
Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients.
In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.